Price
Target price
€66.50
€66.50
-0.750%
-0.5
-0.750%
€73.92
24.04.24 / Stuttgart Stock Exchange
WKN: 659157 / Symbol: RDY / Name: Dr. Reddy's / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dr. Reddy's Laboratories Ltd. ADR Stock
Dr. Reddy's Laboratories Ltd. ADR shows a slight decrease today, losing -€0.500 (-0.750%) compared to yesterday.
Our community is currently high on Dr. Reddy's Laboratories Ltd. ADR with 5 Buy predictions and 1 Sell predictions.
As a result the target price of 73 € shows a slightly positive potential of 9.77% compared to the current price of 66.5 € for Dr. Reddy's Laboratories Ltd. ADR.
Pros and Cons of Dr. Reddy's Laboratories Ltd. ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dr. Reddy's Laboratories Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | -0.750% | 0.758% | -2.920% | 24.299% | 7.258% | 19.820% | 79.730% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 1.790% | 0.000% | -6.557% | -32.544% | -16.788% | -82.831% | -73.733% |
| Almirall S.A. | 1.190% | 4.880% | 5.663% | -7.918% | 0.236% | -34.288% | - |
| Recordati SpA | -1.500% | 0.888% | -3.735% | 23.732% | 2.166% | 7.296% | - |
Comments
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target raised by analysts at Barclays PLC from $75.00 to $80.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for RDY provided by MarketBeat